| 1 |
Guideline [2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers] 2007
Bourguet P, Planchamp F, Montravers F, Vincendeau S, Anonymous00058, Anonymous00059. · Comité rédacteur SOR, INCA, FNCLCC, La Ligue, FHF FNCHRU, FFC et AFU, Centre Eugène Marquis, Rennes, France. · Prog Urol. · Pubmed #17489312 No free full text.
This publication has no abstract.
|
| 2 |
Guideline [Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder] free! 2006
Bourguet P, Planchamp F, Montravers F, Vincendeau S, Courbon F, Edeline V, Helal BO, Rossi D, Villers A, Anonymous00504, Anonymous00505, Anonymous00506, Anonymous00507, Anonymous00508, Anonymous00509, Anonymous00510, Anonymous00511. · Centre Eugène-Marquis, Rennes. · Bull Cancer. · Pubmed #17191352 links to free full text
This publication has no abstract.
|
| 3 |
Review [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers] free! 2003
Bourguet P, Anonymous00059. · Centre Eugène-Marquis, Rennes · Bull Cancer. · Pubmed #12739339 links to free full text
This publication has no abstract.
|
|
|